Skip to main content
. 2022 Feb 14;11(2):383. doi: 10.3390/antiox11020383

Figure 4.

Figure 4

Molecular docking models of α-glucosidase inhibition at catalytic (af) and allosteric sites (gl) by compounds 13 and 57, respectively: (a,g) for kuwanon C (1); (b,h) for moracin M (2); (c,i) for dihydromorin (3); (d,j) for oxyresveratrol (5); (e,k) for norartocarpetin (6); (f,l) for kuwanon G (7).